SELP and COVID-19: Neri et al. in 2020 described that P-selectin plays a role in leukocyte recruitment into the lungs during SARS by other studies using animal models and cell culture thus suggesting that the monoclonal antibody is a possible therapy to treat COVID-19 [103].